The spread of the novel coronavirus has prompted the Food and Drug Administration to temporarily postpone all routine inspections of manufacturing facilities in the U.S. The agency has also directed most employees to begin teleworking.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,